Literature DB >> 16721329

Number of sexual encounters involving intercourse and the transmission of sexually transmitted infections.

Monica K Nordvik1, Fredrik Liljeros.   

Abstract

OBJECTIVE: To investigate the impact of the number of sexual encounters involving intercourse in combination with the number of sexual partners on the transmission dynamics of sexually transmitted infections (STIs). STUDY: A statistical model is used for predicting the basic reproductive rate, R(0), which takes both the number of sexual partners and the number of sexual encounters involving intercourse per partner into consideration. The model is then applied to Swedish survey data that includes data on the number of partners over the course of 1 year, as well as the number of encounters per partner during this time.
RESULTS: The number of sexual encounters involving intercourse in combination with the number of sexual partners affects the number of secondary infections in a nonlinear way. The basic reproductive rate, R(0), is lower when the heterogeneity in number of encounters is modeled than when homogeneity is assumed.
CONCLUSION: The results indicate that it is possible that individuals who have a large number of partners may not, as is often assumed, be the only ones to play a central role as spreaders of STIs. Individuals who have a large number of sexual encounters involving intercourse per partner and have several (but not necessarily a very large number of) partners may also play a significant role in the transmission of STIs.

Entities:  

Mesh:

Year:  2006        PMID: 16721329     DOI: 10.1097/01.olq.0000194601.25488.b8

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

Review 1.  Close encounters of the infectious kind: methods to measure social mixing behaviour.

Authors:  J M Read; W J Edmunds; S Riley; J Lessler; D A T Cummings
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 2.451

2.  A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations.

Authors:  Mark I Chen; Azra C Ghani; W John Edmunds
Journal:  J R Soc Interface       Date:  2008-11-04       Impact factor: 4.118

3.  HIV control in low-income countries in sub-Saharan Africa: are the right things done?

Authors:  Stefan Hanson; Claudia Hanson
Journal:  Glob Health Action       Date:  2008-10-09       Impact factor: 2.640

4.  Stimulating an immune response? Oral sex is associated with less endometritis.

Authors:  R Pittrof; E Sully; D C Bass; S F Kelsey; R B Ness; C L Haggerty
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

5.  Condom use and duration of concurrent partnerships among men in the United States.

Authors:  Irene A Doherty; Victor J Schoenbach; Adaora A Adimora
Journal:  Sex Transm Dis       Date:  2009-05       Impact factor: 2.830

6.  Comparability of results from pair and classical model formulations for different sexually transmitted infections.

Authors:  Jimmy Boon Som Ong; Xiuju Fu; Gary Kee Khoon Lee; Mark I-Cheng Chen
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

7.  Exploiting temporal network structures of human interaction to effectively immunize populations.

Authors:  Sungmin Lee; Luis E C Rocha; Fredrik Liljeros; Petter Holme
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

8.  Determinants of sexual network structure and their impact on cumulative network measures.

Authors:  Boris V Schmid; Mirjam Kretzschmar
Journal:  PLoS Comput Biol       Date:  2012-04-26       Impact factor: 4.475

9.  Epidemics scenarios in the "Romantic network".

Authors:  Alexsandro M Carvalho; Sebastián Gonçalves
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

10.  A mechanistic model of infection: why duration and intensity of contacts should be included in models of disease spread.

Authors:  Timo Smieszek
Journal:  Theor Biol Med Model       Date:  2009-11-17       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.